Bumalik sa Advanced (Grades 10-12) English (UK) – Conversation

Scientific Developments and Responsibility

Ingles senaryo sa pagsasalita

Hollie

A lively British English speaker with a friendly, natural tone.

28 years · female

Practise talking about "Scientific Developments and Responsibility" with Hollie, your AI speaking avatar. Speak out loud, get instant feedback, and build confidence for your Trinity GESE Grade 10-12 speaking exam.

Start free AI practice

Pag-uusap

What makes scientific developments and responsibility an important subject to discuss?

Magandang sagot:

Scientific developments matter because they can improve life very quickly, but they can also create risks before society has agreed how to manage them. Medical research, genetic testing and artificial intelligence can help people live longer, make better decisions and solve problems that once seemed impossible. At the same time, they raise questions about privacy, inequality, consent and control. The issue is not simply whether science is good or bad. It is about who benefits, who carries the risk, and who has enough knowledge to take part in decisions that may affect everyone in daily life, not only specialists in laboratories or boardrooms.

How has this issue changed in recent years?

Magandang sagot:

The biggest change is speed. New technologies can now move from research to public use extremely quickly, especially in areas like artificial intelligence, biotechnology and data science. In the past, many scientific developments reached ordinary people through slower institutions, such as hospitals or universities. Now private companies can release powerful tools directly to millions of users. The consequence is that regulation often arrives late. Society may only understand the risks after people have already changed their behaviour, shared data or become dependent on a new system at work or at home, sometimes without real consent or much explanation beforehand or afterwards.

Do you think people usually discuss this issue in a fair way?

Magandang sagot:

I do not think public debate is always fair, because science is often presented either as salvation or as danger. Some people assume every innovation is progress, while others react as if new technology is automatically threatening. Both views are too simple. A fair discussion should ask what problem the development solves, what evidence supports it, who gains power from it and who may be exposed to risk. It should also distinguish between a possible danger and a proven harm. Without that distinction, the debate becomes emotional rather than responsible or useful for public decisions about science policy and trust.

What would be a sensible way for society to respond?

Magandang sagot:

A sensible response would be flexible regulation. Scientific developments should not be blocked simply because they are new, but they should not be released without scrutiny either. Governments, researchers and independent bodies should assess risks early, then update rules as evidence changes. The benefit is that society can encourage innovation while still protecting the public. The risk is that regulation may become too slow or too influenced by industry. To avoid that, oversight needs expertise, transparency and real independence from the companies or institutions hoping to profit from the development they are assessing and promoting publicly or commercially later too.

How might your view change in the future?

Magandang sagot:

I would revise my position if research showed that strict oversight was preventing important discoveries from reaching people who needed them. I believe responsibility is essential, but regulation can also cause harm if it delays treatments, safer technologies or useful research without good reason. I would want to compare the risks of action with the risks of inaction. If careful evidence showed that a lighter approach protected people just as well while allowing faster progress, I would support that. My concern is not control for its own sake, but responsible benefit for society, patients and future users, not just researchers or investors.